Fink, 1998 - Google Patents
Expression of a fully active, monomeric catalytic fragment of the cyclic GMP-binding cyclic GMP-specific phosphodiesterase (PDE5)Fink, 1998
- Document ID
- 8757368063599436786
- Author
- Fink T
- Publication year
External Links
Snippet
Phosphodiesterases (PDEs) comprise a superfamily of phosphohydrolases that degrade 3′, 5′-cyclic nucleotides. All known mammalian PDEs are dimeric, but the functional significance of dimerization is unknown. A deletion mutant of cGMP-binding cGMP-specific …
- 230000003197 catalytic 0 title abstract description 54
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2243208T3 (en) | HUMAN CYCLIC NUCLEOTIDE PHOSPHODESTERASE. | |
| ES2284502T3 (en) | 22025, A NEW HUMAN PHOSPHODIESTERASE CYCLIC NUCLEOTIDE. | |
| US20020115176A1 (en) | Phosphodiesterase enzymes | |
| US6255456B1 (en) | Cyclic GMP phosphodiesterase | |
| JP2002504804A (en) | Cyclic nucleotide phosphodiesterase | |
| US6566087B1 (en) | Phosphodiesterase 8A | |
| Saldou et al. | Comparison of recombinant human PDE4 isoforms: interaction with substrate and inhibitors | |
| US6734003B2 (en) | Phosphodiesterase 10 | |
| WO2006116322A2 (en) | Nicotinamide riboside kinase compositions and methods for using the same | |
| JPH08508877A (en) | Protein tyrosine phosphatase PTP-S31 | |
| JP2704880B2 (en) | Angiogenin inhibitors | |
| JP2001520508A (en) | Insulin resistance treatment | |
| POOLEY et al. | Intracellular localization of the PDE4A cAMP-specific phosphodiesterase splice variant RD1 (RNPDE4A1A) in stably transfected human thyroid carcinoma FTC cell lines | |
| Richter et al. | Identification of inhibitor binding sites of the cAMP-specific phosphodiesterase 4 | |
| US20040137508A1 (en) | Enzyme PDE XVI | |
| Fink | Expression of a fully active, monomeric catalytic fragment of the cyclic GMP-binding cyclic GMP-specific phosphodiesterase (PDE5) | |
| US7052895B2 (en) | Phosphodiesterase enzymes | |
| Brandon et al. | Cyclic-nucleotide phosphodiesterases in the central nervous system: from biology to drug discovery | |
| CA2291881A1 (en) | Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes | |
| US20040254094A1 (en) | Suppression of cyclin kinase activity for prevention and treatment of infections | |
| ES2359233T3 (en) | HOMOLOGICAL PROTEINS OF THE MNK KINASE INVOLVED IN THE REGULATION OF ENERGY HOMEOSTASIS AND ORGANULAR METABOLISM. | |
| WO2002030410A2 (en) | Suppression of cyclin kinase activity for prevention and treatment of infections | |
| JP4205630B2 (en) | Phosphodiesterase enzyme | |
| JP3980635B2 (en) | Methods and products for modulating cellular responsiveness to external signals | |
| Korniotis | Expression studies of recombinant cAMP-specific phosphodiesterase type 4 |